United States - English - NLM (National Library of Medicine)

uriel pharmacy inc - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 2 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 6 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 2 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - hawthorn leaf with flower (unii: 6om09rpy36) (hawthorn leaf with flower - unii:6om09rpy36), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), equisetum arvense top (unii: 1dp6y6b65z) (equisetum arvense top - unii:1dp6y6b65z) - hawthorn leaf with flower 3 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - directions: for oral use. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - hawthorn leaf with flower (unii: 6om09rpy36) (hawthorn leaf with flower - unii:6om09rpy36), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), equisetum arvense top (unii: 1dp6y6b65z) (equisetum arvense top - unii:1dp6y6b65z) - directions: for oral use only. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

greenstone llc - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide capsules are contraindicated in patients with congenital or acquired long qt syndromes. dofetilide capsules should not be used in patients wi

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide capsules can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide capsules are contraindicated in patients with congenital or acquired long qt syndromes. dofetilide capsules should not be used in pa

United States - English - NLM (National Library of Medicine)

bionpharma inc. - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide has not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide is contraindicated in patients with congenital or acquired long qt syndromes. dofetilide should not be used in patients with a baseline